A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.
- A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
The Journal of Headache and Pain
Volume 11, Issue 2 , pp 175-178
- Cover Date
- Print ISSN
- Online ISSN
- Springer Milan
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore
- 2. Department of Clinical Research, Singapore General Hospital, Singapore, Singapore